Zimmer Biomet and OneStep Transform Joint Replacement Recovery with Innovative Technology Partnership

Zimmer Biomet Partners with OneStep to Revolutionize Joint Replacement Recovery

Zimmer Biomet Holdings, Inc., a leader in medical technology, announces an exclusive collaboration with OneStep, a digital fall prevention and mobility intelligence platform. This partnership is set to significantly enhance recovery monitoring for patients undergoing joint replacement surgeries. The integration of OneStep's advanced gait and mobility analytics into Zimmer Biomet's mymobility® Care Management Platform allows surgeons to track recovery progress more effectively. Furthermore, it empowers patients to take an active role in their rehabilitation, providing them with daily objective insights from pre-surgery through recovery.

The mymobility platform, accessible on both iPhone and Android devices, facilitates remote assessments of a patient's gait and functional mobility. This technological advancement marks a significant shift towards personalized care in the orthopedic industry, according to Robert Kraal, Vice President and General Manager of Connected Health at Zimmer Biomet. By leveraging clinically validated technology, this collaboration aims to minimize the burden on both patients and clinicians while enhancing the measurement of patient mobility, ultimately improving functional outcomes post-surgery.

Zimmer Biomet’s collaboration with OneStep aligns with its broader connected care strategy, which seeks to merge technology and data-driven solutions to improve patient outcomes in joint replacement surgeries. The integration not only represents a step forward in orthopedic recovery but also reflects the company's commitment to enhancing patient engagement through innovative solutions. As the healthcare industry increasingly adopts digital tools for monitoring and improving patient care, this partnership positions Zimmer Biomet at the forefront of transforming orthopedic practices.

In additional developments, Sealing Technologies (SealingTech), a subsidiary of Parsons Corporation, recently received a contract modification from the Department of War's Defense Innovation Unit to enhance its Joint Cyber Hunt Kit prototype. This initiative aims to bolster defensive cyber capabilities for U.S. Cyber Command and the UK's Joint Defensive Cyber Unit, showcasing SealingTech's commitment to advancing cybersecurity solutions.

Meanwhile, Co-Diagnostics, Inc. is set to participate in the 2nd Advanced TB Diagnostics Course in Chennai, India, through its joint venture CoSara Diagnostics. This workshop aims to address tuberculosis detection and research needs in the South-East Asian Region, highlighting Co-Diagnostics’ ongoing dedication to global health initiatives.